Efficacy of Artificial Tears Based on an Extract of


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
05 Nov 2021
Historique:
received: 03 10 2021
revised: 29 10 2021
accepted: 03 11 2021
entrez: 13 11 2021
pubmed: 14 11 2021
medline: 7 1 2022
Statut: epublish

Résumé

(1) Background:

Identifiants

pubmed: 34769429
pii: ijms222111999
doi: 10.3390/ijms222111999
pmc: PMC8584318
pii:
doi:

Substances chimiques

Dinucleoside Phosphates 0
Lubricant Eye Drops 0
Plant Extracts 0
Hypromellose Derivatives 3NXW29V3WO

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Nature. 2014 May 15;509(7500):310-7
pubmed: 24828189
J Ocul Pharmacol Ther. 2018 Nov;34(9):612-620
pubmed: 30325678
Sci Rep. 2021 Mar 26;11(1):6989
pubmed: 33772064
Nanoscale. 2019 Mar 21;11(12):5580-5594
pubmed: 30860532
Prog Retin Eye Res. 2016 Nov;55:182-205
pubmed: 27421962
Arq Bras Oftalmol. 2019 Jul-Aug;82(4):310-316
pubmed: 31038554
Exp Eye Res. 2015 May;134:141-7
pubmed: 25701803
Br J Pharmacol. 2015 Feb;172(4):1045-58
pubmed: 25297531
Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):739-750
pubmed: 29484560
Curr Eye Res. 2015 Sep;40(9):878-83
pubmed: 25310688
PLoS One. 2012;7(3):e33688
pubmed: 22438984
Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):5108-5115
pubmed: 30372737
J Ocul Pharmacol Ther. 2015 Dec;31(10):631-5
pubmed: 26630617
Invest Ophthalmol Vis Sci. 2001 Jan;42(1):96-100
pubmed: 11133853
Eye Contact Lens. 2020 Mar;46 Suppl 2:S57-S63
pubmed: 32068662
Br J Pharmacol. 2012 Feb;165(4b):1163-72
pubmed: 21740413
Curr Eye Res. 2015 Sep;40(9):913-22
pubmed: 25329624
Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4500-6
pubmed: 17003445
Mol Vis. 2009 Jun 11;15:1169-78
pubmed: 19521552
Korean J Ophthalmol. 2020 Feb;34(1):1-10
pubmed: 32037744
Purinergic Signal. 2011 Jun;7(2):243-9
pubmed: 21559786
Biomater Sci. 2018 Nov 20;6(12):3160-3169
pubmed: 30357138
Exp Eye Res. 2019 Jul;184:91-100
pubmed: 31004572
J Biol Chem. 1963 Jan;238:344-8
pubmed: 13945193
Medicine (Baltimore). 2017 Sep;96(39):e8174
pubmed: 28953672
Ophthalmic Res. 2019;61(4):188-198
pubmed: 30654362
J Ocul Pharmacol Ther. 2002 Aug;18(4):363-70
pubmed: 12222766
Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):255-264
pubmed: 30649152
Ocul Surf. 2017 Jul;15(3):334-365
pubmed: 28736337
Ocul Surf. 2017 Jul;15(3):366-403
pubmed: 28736338
Curr Eye Res. 2021 Feb;46(2):174-178
pubmed: 32602751
J Biol Chem. 1978 Jul 25;253(14):4960-5
pubmed: 670172
Clin Ophthalmol. 2015 Jun 09;9:1029-31
pubmed: 26089634
PLoS One. 2016 Jun 23;11(6):e0157982
pubmed: 27336157
Purinergic Signal. 2005 Sep;1(3):281-92
pubmed: 18404512
J Pharmacol Exp Ther. 2013 Jun;345(3):331-41
pubmed: 23504005
Purinergic Signal. 2004 Dec;1(1):83-90
pubmed: 18404404
Neuropharmacology. 2016 May;104:18-30
pubmed: 26231831
J Cell Biochem. 2004 Dec 15;93(6):1115-33
pubmed: 15449317
Int J Nanomedicine. 2018 Nov 08;13:7251-7273
pubmed: 30510416
Ophthalmic Physiol Opt. 2004 May;24(3):186-93
pubmed: 15130167
Curr Eye Res. 2016 Sep;41(9):1150-2
pubmed: 26863584
Jpn J Ophthalmol. 2015 Nov;59(6):415-20
pubmed: 26310103
Adv Pharmacol. 2011;61:373-415
pubmed: 21586365
J Pharmacol Exp Ther. 2002 Jan;300(1):291-7
pubmed: 11752128
Clin Ophthalmol. 2008 Jun;2(2):261-7
pubmed: 19668714
Ocul Surf. 2017 Jul;15(3):575-628
pubmed: 28736343
Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4982-92
pubmed: 18641289
Expert Opin Drug Metab Toxicol. 2014 Jun;10(6):905-13
pubmed: 24797483
Curr Eye Res. 2011 Dec;36(12):1108-15
pubmed: 21988553
J Ocul Pharmacol Ther. 2018 Jan/Feb;34(1-2):170-176
pubmed: 28700254
PLoS One. 2016 Apr 21;11(4):e0153573
pubmed: 27100624
Ocul Surf. 2017 Jul;15(3):276-283
pubmed: 28736335
Curr Eye Res. 2019 May;44(5):486-496
pubmed: 30580651
Jpn J Ophthalmol. 2013 Sep;57(5):440-6
pubmed: 23740285
J Ophthalmol. 2020 May 30;2020:7204951
pubmed: 32566267
Clin Ophthalmol. 2015 Dec 01;9:2251-6
pubmed: 26664039
J Ocul Pharmacol Ther. 2017 Jul/Aug;33(6):493-497
pubmed: 28346860
Cornea. 2008 May;27(4):395-401
pubmed: 18434840
Adv Exp Med Biol. 2002;506(Pt A):261-5
pubmed: 12613918
Sci Rep. 2017 Aug 24;7(1):9380
pubmed: 28839279

Auteurs

Carlos Carpena-Torres (C)

Ocupharm Research Group, Department of Optometry and Vision, Faculty of Optics and Optometry, Complutense University of Madrid, C/Arcos de Jalón 118, 28037 Madrid, Spain.

Jesus Pintor (J)

Ocupharm Research Group, Department of Biochemistry and Molecular Biology, Faculty of Optics and Optometry, Complutense University of Madrid, C/Arcos de Jalón 118, 28037 Madrid, Spain.

Fernando Huete-Toral (F)

Ocupharm Research Group, Department of Biochemistry and Molecular Biology, Faculty of Optics and Optometry, Complutense University of Madrid, C/Arcos de Jalón 118, 28037 Madrid, Spain.

Alba Martin-Gil (A)

Ocupharm Research Group, Department of Optometry and Vision, Faculty of Optics and Optometry, Complutense University of Madrid, C/Arcos de Jalón 118, 28037 Madrid, Spain.

Candela Rodríguez-Pomar (C)

Ocupharm Research Group, Department of Optometry and Vision, Faculty of Optics and Optometry, Complutense University of Madrid, C/Arcos de Jalón 118, 28037 Madrid, Spain.

Alejandro Martínez-Águila (A)

Ocupharm Research Group, Department of Biochemistry and Molecular Biology, Faculty of Optics and Optometry, Complutense University of Madrid, C/Arcos de Jalón 118, 28037 Madrid, Spain.

Gonzalo Carracedo (G)

Ocupharm Research Group, Department of Optometry and Vision, Faculty of Optics and Optometry, Complutense University of Madrid, C/Arcos de Jalón 118, 28037 Madrid, Spain.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH